Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 116.82 |
| Bid (Size) | 116.34 (100) |
| Ask (Size) | 117.40 (100) |
| Prev. Close | 116.82 |
| Today's Range | 116.82 - 116.82 |
| 52wk Range | 61.23 - 119.21 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
2.0% below 52-week high
116.82
61.2352W Low
119.2152W High
1 Week
2.0% below 1-week high
107.411W Low
119.211W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $119.21 over the past 52 weeks and last traded at $116.82, 2.0% below its 52-week high. Over the past week it ranged between $107.41 and $119.21.
Past 12 Months
1W
+$6.98
1M
+$8.88
3M
+$41.00
6M
+$48.77
YTD
+$46.51
1Y
+$50.17
HALO was +75.3% over the past year, +71.7% over six months, +66.1% year to date, +6.4% in the last week.
12 Months vs Market
HALO
+75.3%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%
Over the past 12 months HALO returned +75.3% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.
Volume & Liquidity
1W
2.3M
1M
2.7M
3M
2.2M
6M
2.0M
YTD
2.0M
1Y
2.0M
HALO's 3-month average daily volume is 2.2M.
More News
Read More
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 116.82
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/14/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 16.63B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 17B shares outstanding.